About Us

Meet the team simplifying genomics

SeqOnce is accelerating life science discoveries and improving the human condition. From NGS to new detection technologies, we unlock hidden potential in existing platforms

Real-world solutions for real-world science.

Founded in 2014, SeqOnce was spun out of USC and is privately held. The founders have complementary skill sets with CSO Joseph Dunham’s strong background in molecular biology and technology development, James Gilmore in molecular biology and commercialization, and CEO Chris Angermayer’s expertise in finance and operations. SeqOnce is growing rapidly as it continues to launch new products in genomics, food safety, and pathogen detection.

Want to accelerate your sequencer or your CLIA lab? How about your career?

Board of directors

Chris Mason, PhD

Scientific Advisor

Scott Tighe, PhD

Scientific Advisor

Scott Fraser, PhD

Scientific Advisor

Martin Pieprzyk

Advisor

Sergey Nuzhdin, PhD

Scientific Advisor

Michael Giardello, PhD

Board Member

Investors

Actively seeking new investment. Contact us for more information.

Chris Angermayer

CEO & CO-FOUNDER
Linkedin

Joseph P. Dunham, PhD

CSO & CO-FOUNDER
Linkedin

Tim Harkins, PhD

COO
Linkedin
Contact
Distributors
About
About Us
Conservation
Copyright 2023 Seqonce Biosciences. All Rights Reserved. Provisional Owner/Operator FDA Registration Number: 10076042 Designed by Hubble Design Group. Built & Managed by MITO Studios